Home

Samrat Pharmachem Ltd EPS

Image

Samrat Pharmachem Ltd

NSE: SAMRATPHARMA

EPS

₹ 5.08

Last updated on: Dec 01, 2025

Key Highlights

  • The Earning per Share of Samrat Pharmachem Ltd is ₹ 5.08 as of 01 Dec 25 .
  • The earning per share of Samrat Pharmachem Ltd changed from ₹ 1.98 to ₹ -1.9 over 10 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Samrat Pharmachem Ltd

No data available

* All values are in

Company Fundamentals for Samrat Pharmachem Ltd

Market Cap

75 Cr

EPS

5.1

P/E Ratio (TTM)

48.3

P/B Ratio (TTM)

1.1

Day’s High

270.0

Day’s Low

249.9

DTE

0.2

ROE

2.2

52 Week High

449.45

52 Week Low

245.0

ROCE

4.9

Market Price of Samrat Pharmachem Ltd

1M

1Y

3Y

5Y

Monitoring Samrat Pharmachem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
01 Dec 2025245.3
28 Nov 2025255.4
27 Nov 2025255.3
26 Nov 2025255.45
25 Nov 2025265
24 Nov 2025269.15
21 Nov 2025270.1
20 Nov 2025274.15
19 Nov 2025274.65
18 Nov 2025269.2

BlinkX Score for Samrat Pharmachem Ltd

Asset Value vs Market Value of Samrat Pharmachem Ltd

Market Value

76

-0.3 X

Value addition

Asset Value

104

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Samrat Pharmachem Ltd75.79
Sun Pharmaceutical Industries Ltd433764
Divis Laboratories Ltd170489
Torrent Pharmaceuticals Ltd126436
Cipla Ltd123088
Dr Reddys Laboratories Ltd105162

Historical Market Cap of Samrat Pharmachem Ltd

No data available

* All values are in crore

Historical Revenue of Samrat Pharmachem Ltd

No data available

* All values are in crore

Historical EBITDA of Samrat Pharmachem Ltd

No data available

* All values are in crore

Historical Net Profit of Samrat Pharmachem Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Samrat Pharmachem Ltd News Hub

Samrat Pharmachem standalone net profit rises 239.34% in the June 2024 quarter

Net profit of Samrat Pharmachem rose 239.34% to Rs 2.07 crore in the quarter ended June 2024 as agai

Read more

13 Aug 24

Samrat Pharmachem announces board meeting date

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024.

Read more

28 Sept 24

Samrat Pharmachem to declare Quarterly Result

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 February 2025.

Read more

31 Dec 24

Samrat Pharmachem reports standalone net profit of Rs 2.66 crore in the September 2024 quarter

Net profit of Samrat Pharmachem reported to Rs 2.66 crore in the quarter ended September 2024 as aga

Read more

15 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Samrat Pharmachem Ltd

What is the EPS of Samrat Pharmachem Ltd stock?

The Earnings Per Share (EPS) of Samrat Pharmachem Ltd is 5.08. An EPS is the amount of net income attributed to each share of a common stock.

How is Samrat Pharmachem Ltd EPS calculated?

The EPS of Samrat Pharmachem Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Samrat Pharmachem Ltd report its EPS?

Samrat Pharmachem Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Samrat Pharmachem Ltd EPS?

Factors that influence the EPS of Samrat Pharmachem Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Samrat Pharmachem Ltd EPS growth indicate future performance?

Yes, consistent growth in Samrat Pharmachem Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions